Stephen V Liu, MD
@StephenVLiu
Followers
28K
Following
97K
Media
7K
Statuses
20K
Chief of Hematology and Oncology @Georgetown University; Director of Developmental Therapeutics @LombardiCancer; Co-Chair #DCLung25 and #TexasLung26; #HereWeGo
Georgetown, Washington, DC
Joined September 2011
RT @myESMO: In the Diary of an Oncology Leader video series by #ESMOW4O @marinagarassino shares the key lessons that continue to influence….
0
4
0
RT @g_mountzios: Back in Zurich for another exceptional @etop_ibcsg workshop, now focusing on T-cell engagers (TCE) and their unprecedente….
0
11
0
RT @IASLC: The #FDA has approved sunvozertinib for patients with #EGFR exon 20 insertions, but what sets this therapy apart? On #LungCancer….
0
9
0
Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference!. Dr. Zosia Piotrowska @ZPiotrowskaMD joins to discuss targeting EGFR exon 20 and atypical mutations. Register today!.
2
5
20
Next week's episode of the @IASLC podcast, Lung Cancer Considered, previews the upcoming North American Conference on Lung Cancer #NACLC25, coming December 5-7 in Chicago. Joining me are co-chairs Drs. @rarengan and @kamarroneMD on behalf of @ChristineBestv1 @ErinGillaspie
2
3
27
RT @tnewsomdavis: @DrRiyazShah is being very modest here: he was the first clinician to raise this issue with @NHSEngland team and so this….
0
5
0
Join us at #DCLung25 on Saturday, October 4th in downtown Washington, DC for the latest updates in lung cancer. Dr. Charu Aggarwal @CharuAggarwalMD joins the faculty to discuss early stage NSCLC. @IASLC endorsed & CME / MOC credits - register today!.
1
3
17
RT @TargetedOnc: Stephen Liu, MD, (@StephenVLiu) discussed the rationale behind the IMforte study, its methodology, and the transformative….
0
8
0
RT @MedStarGUH: Dr. Kimberley Doucette is a board-certified medical oncologist and hematologist at MedStar Georgetown University Hospital,….
0
1
0
RT @StephenVLiu: The latest episode of the @IASLC podcast previews the upcoming #WCLC25 meeting with the four co-chairs: Drs. @DrJNaidoo @U….
0
10
0
A practical guide on managing toxicities from lorlatinib chronically now @LungCaJournal, developed collaboratively by patients with #ALK NSCLC @ALKPositiveinc.
2
31
91
RT @LAGurwitch: Meet me in DC. I'll be the very caffeinated person running to attend the presentations of all of the brilliant people I fol….
0
5
0
RT @Lung_Cancers: 🫁 How are IMFORTE and DeLLphi-304 changing the standard of care for SCLC?. 🌟 In this insightful new interview, @StephenVL….
0
12
0
Prospective study of stereotactic radiation for treatment of brain metastases (1-10) in SCLC (instead of whole brain radiation) @JCO_ASCO. In 100 pts (median number of metastases was 2), only 22% of pts required salvage WBRT, mOS 10.2m.
1
31
68
The @IASLC podcast is in many different languages! This episode in Mandarin Chinese hosted by Dr. @susu_mail0513 features a discussion on #EGFR NSCLC with Dr. Wenfeng Fang and Dr. Xiaorong Dong.
0
3
22
RT @DrJNaidoo: Superb @etop_ibcsg T-cell engager workshop exploring next steps in thoracic tumors & academic trials. Stellar talks, includi….
0
9
0
RT @IASLC: How is EGFR-mutant #NSCLC managed in Brazil? In this episode of #LungCancerConsidered, @clarissamathias moderates a discussion w….
0
11
0
Fantastic first day at the ETOP Workshop on T Cell Engagers. Reviewing the data, previewing the future, devising ways to overcome barriers to implementation. Great to engage with friends in Zurich! @etop_ibcsg
1
11
67